IMAX.NYSEImax CORP

DEF: IMAX 2026 Proxy: Record 2025 Performance and CEO Extension

Sentiment:

Definitive Proxy Statement


IMAX Corporation reports record 2025 financial performance and outlines proposals for its 2026 Annual General Meeting, including executive compensation and director elections.

Better than expectedRecord global box office, market share, and revenue achieved in 2025.Total Adjusted EBITDA and Net Income grew significantly by 33% and 39% respectively.System installations reached the high end of annual projections.

Summary

  • IMAX achieved record global box office, market share, and revenue in 2025.
  • Total revenue reached $410.2 million, a 16% increase from 2024.
  • Total Adjusted EBITDA grew 33% to $184.9 million, with a margin of 45.1%.
  • The company signed agreements for 166 new and upgraded theater systems and completed 160 installations.
  • Shareholders will vote on director elections, auditor appointment, and advisory executive compensation at the June 10, 2026, Annual General Meeting.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a highly positive filing, reflecting record-breaking financial results, strong operational execution, and clear strategic alignment with shareholder interests.

Positives

  • Record financial performance with 40% growth in global box office and 16% growth in total revenue.
  • Strong profitability improvement, with Net Income Margin rising to 11% and Total Adjusted EBITDA Margin to 45%.
  • Robust network expansion with 166 new system signings and 160 installations.
  • Strong shareholder returns with a 44% increase in share price during 2025.
  • High level of shareholder support, with 95% of votes cast in favor of the 2025 say-on-pay proposal.

Negatives

  • CEO Richard Gelfond is currently on a temporary medical leave of absence.
  • The company reported a $7 million goodwill impairment in 2025.
  • The company incurred $15.26 million in induced conversion expenses related to the settlement of convertible notes.

Risks

  • Reliance on a robust film slate and the ability to secure premium content from major studios.
  • Potential for actual results to differ from forward-looking statements due to industry and market factors.
  • Risks associated with the company's global footprint and operations in over 90 countries.
  • Cybersecurity and data privacy risks inherent in digital technology operations.

Future Outlook

The company anticipates a strong 2026 lineup of 'Filmed For IMAX' releases, including 'The Mandalorian & Grogu', 'Narnia', 'Dune: Part Three', and Christopher Nolan's 'The Odyssey'. Management remains focused on expanding the network and driving utilization through live events, music, gaming, and sports.

Management Comments

  • IMAX delivered the strongest performance in our history in 2025, cementing our position as a premier global platform for awe-inspiring experiences.
  • We are energized by our historic success, but even more excited about the opportunity ahead to grow and deliver strong returns for our shareholders.

Industry Context

StockSavvy.ai notes that IMAX continues to differentiate itself through its proprietary technology and 'Filmed For IMAX' strategy, which remains a key competitive advantage in a crowded theatrical market. The company's pivot toward diversifying content beyond traditional films into live events and sports aligns with broader industry trends seeking to maximize theater utilization.

Comparison to Industry Standards

  • IMAX's three-year TSR of 152% places it at approximately the 98th percentile of its performance peer group.
  • The company's 45.1% Total Adjusted EBITDA margin demonstrates superior operating efficiency compared to traditional exhibition peers.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Interim Principal Executive OfficerN/ARobert D. Lister2026-04-16Temporary medical leave of absence for CEO Richard Gelfond.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Employment Agreement AmendmentThird amendment to CEO Richard Gelfond's employment agreement.2026-01-01Extends term to December 31, 2028 and increases target equity grant value to $7.0 million.

Related Party Transactions

  • Kevin Douglas, the company's largest individual shareholder, holds approximately 15.23% of common shares; the Board determined he has no material interest in any transactions with the company.

Stakeholder Impact

  • Shareholders benefit from strong financial performance and share price growth.
  • Employees benefit from continued investment in human capital and engagement programs.
  • Exhibitor partners benefit from the continued expansion of the IMAX network.

Next Steps

  • Hold 2026 Annual General Meeting of Shareholders on June 10, 2026.
  • Execute 2026 'Filmed For IMAX' content strategy.
  • Continue development of potential successors for key senior leadership positions.

Key Dates

DateDescription
2026-04-13Record date for shareholders entitled to vote at the Annual General Meeting.
2026-04-24Release date of the Proxy Circular and Proxy Statement.
2026-06-08Deadline for receipt of proxies for the Annual General Meeting.
2026-06-102026 Annual General Meeting of Shareholders.

Recommendation

buy

The company is demonstrating record financial growth, strong operational execution, and high shareholder alignment, making it a compelling investment for long-term growth.

Keywords

IMAX, Entertainment Technology, Proxy Statement, Executive Compensation, Corporate Governance, Box Office, Filmed For IMAX

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.